The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a ...

Fat molecules known as PUFAs can help lessen nerve damage in amyotrophic lateral sclerosis (ALS), a study suggests.

Nature ion channels play significant role in the living organisms, which can translocate physiological relevant ions across the cell membranes as demand. To simulate and replace the function of nature ...

Olpasiran leads to significant and sustained reduction in oxidized phospholipids on apolipoprotein B. HealthDay News — Olpasiran, a small interfering RNA, which blocks lipoprotein(a ...

leads to a significant and sustained reduction in oxidized phospholipids (OxPL) on apolipoprotein B (apoB), according to a study published online Feb. 12 in JAMA Cardiology. Robert S. Rosenson ...

OLPASIRAN significantly reduces oxidized phospholipids on apolipoprotein B in patients with atherosclerotic cardiovascular disease and elevated lipoprotein(a) levels, but has no effect on systemic ...